Drug Shortage Report for ENALAPRILAT INJECTION USP
| Report ID | 231317 |
| Drug Identification Number | 02388499 |
| Brand name | ENALAPRILAT INJECTION USP |
| Common or Proper name | ENALAPRILAT INJECTION USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ENALAPRILAT |
| Strength(s) | 1.25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 2mL vial |
| ATC code | C09AA |
| ATC description | ACE INHIBITORS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-07-12 |
| Actual start date | |
| Estimated end date | 2025-05-02 |
| Actual end date | 2025-05-07 |
| Shortage status | Resolved |
| Updated date | 2025-05-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2025-05-08 | English | Compare |
| v17 | 2025-05-07 | French | Compare |
| v16 | 2025-05-07 | English | Compare |
| v15 | 2025-04-25 | French | Compare |
| v14 | 2025-04-25 | English | Compare |
| v13 | 2025-04-01 | French | Compare |
| v12 | 2025-04-01 | English | Compare |
| v11 | 2025-03-03 | French | Compare |
| v10 | 2025-03-03 | English | Compare |
| v9 | 2025-01-28 | French | Compare |
| v8 | 2025-01-28 | English | Compare |
| v7 | 2024-11-13 | French | Compare |
| v6 | 2024-11-13 | English | Compare |
| v5 | 2024-10-11 | French | Compare |
| v4 | 2024-10-11 | English | Compare |
| v3 | 2024-07-13 | English | Compare |
| v2 | 2024-06-26 | French | Compare |
| v1 | 2024-06-26 | English | Compare |
Showing 1 to 18 of 18